Similar to This
AstraZeneca might develop cancer vaccines, CEO Pascal Soriot says
AstraZeneca might develop cancer vaccines, CEO Pascal Soriot says
dlvr.it/TW5w9d
AstraZeneca boss urges western drugmakers to move at ‘Chinese speed’
AstraZeneca boss urges western drugmakers to move at ‘Chinese speed’: Europe and US risk being outpaced on innovation, as happened in the car industry ...
theguardian.com/business/2026/jul/27/astrazeneca-boss-urges-western-drugmakers-to-move-at-chinese-speed
AstraZeneca CEO Pascal Soriot delivers remarks as firm celebrates transfer ...
AstraZeneca CEO Pascal Soriot delivers remarks as firm celebrates transfer to NYSE
qz.com/astrazeneca-ceo-pascal-soriot-nyse-transfer
Dividend guarantor AstraZeneca keeps growing – pharmaceutical giant on ...
Dividend guarantor AstraZeneca keeps growing – pharmaceutical giant on track: AstraZeneca exceeds expectations with Q3 growth and confirms targets for 2030.
deraktionaer.de/artikel/pharma-biotech/dividenden-garant-astrazeneca-waechst-und-waechst-pharma-riese-auf-kurs-20389877.html
NHS won’t get cutting-edge drugs unless it pays more, says AstraZeneca ...
NHS won’t get cutting-edge drugs unless it pays more, says AstraZeneca boss: Pascal Soriot says cost-effectiveness thresholds for new medicines have not changed ...
theguardian.com/business/2025/nov/06/uk-will-only-be-able-to-afford-generic-drugs-if-nhs-fails-to-pay-more-says-astrazeneca-boss
AstraZeneca’s listing rejig spells long-term danger for London
AstraZeneca’s listing rejig spells long-term danger for London: It’s not skipping off entirely to New York, but pharma giant sets a worrying precedent for UK ...
theguardian.com/business/nils-pratley-on-finance/2025/sep/29/astrazenecas-listing-rejig-spells-long-term-danger-for-london
AstraZeneca pledges $50bn investment in the US amid 200% tariff fears
AstraZeneca pledges $50bn investment in the US amid 200% tariff fears: British-Swedish pharmaceutical company AstraZeneca is expanding its presence in the US in ...
euronews.com/business/2025/07/22/astrazeneca-pledges-50bn-investment-in-the-us-amid-200-tariff-fears
Astrazeneca chief ‘wants to shift London listing to US’
Astrazeneca chief ‘wants to shift London listing to US’: The boss of Astrazeneca has reportedly voiced his desire to transfer the pharma giant's listing to the ...
cityam.com/astrazeneca-chief-wants-to-shift-listing-to-us/
AstraZeneca boss ‘wants to shift stock market listing to US’
AstraZeneca boss ‘wants to shift stock market listing to US’: Report claims CEO Pascal Soriot talked in private about moving UK’s most valuable listed company ...
theguardian.com/business/2025/jul/01/astrazeneca-boss-wants-to-shift-stock-market-listing-to-us
Drugmaker AstraZeneca shifts more production to US amid Trump tariffs
Drugmaker AstraZeneca shifts more production to US amid Trump tariffs: UK and rest of Europe risk losing out to US and China unless they ramp up spending on new ...
theguardian.com/business/2025/apr/29/astrazeneca-production-us-trump-tariffs-uk-europe-pascal-soriot
Is any CEO worth the £18.7m AstraZeneca wants to pay boss Pascal Soriot?
Is any CEO worth the £18.7m AstraZeneca wants to pay boss Pascal Soriot?: Pascal Soriot was already the highest-paid leader of a FTSE 100 company ...
independent.co.uk/independentpremium/business/astrazeneca-salary-pascal-soriot-b2527111.html
AstraZeneca CEO set to earn £18.7 million after shareholder backing
AstraZeneca CEO set to earn £18.7 million after shareholder backing: More than 60% of shareholders backed the decision to raise Pascal Soriot’s pay packet ...
euronews.com/business/2024/04/12/astrazeneca-ceo-set-to-earn-187-million-after-shareholder-backing
Top chief execs ‘paid more in a year than a UK worker gets in a lifetime’
Top chief execs ‘paid more in a year than a UK worker gets in a lifetime’: Despite a fall in remuneration during the Covid pandemic, blue chip company bosses ...
theguardian.com/business/2021/aug/19/top-chief-execs-paid-more-in-a-year-than-a-uk-worker-gets-in-a-lifetime
Head of Covid vaccine maker AstraZeneca tops CEO pay chart in UK with $18 ...
Head of Covid vaccine maker AstraZeneca tops CEO pay chart in UK with $18 million
wionews.com/world/head-of-covid-vaccine-maker-astrazeneca-tops-ceo-pay-chart-in-uk-with-18-million-406725
Will the AstraZeneca share price be the largest FTSE 100 riser in 2021? - ...
Will the AstraZeneca share price be the largest FTSE 100 riser in 2021? - The Motley Fool UK
fool.co.uk/investing/2020/12/29/will-the-astrazeneca-share-price-be-the-largest-ftse-100-riser-in-2021/